Anne Marie Guedj

Anne Marie Guedj

Auto-generated profile, based on publicly available information

Anne Marie Guedj

CHU de Nîmes, Nîmes, France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VCValeria Cosma
Valeria Cosma
JIJeanne Imbernon
Jeanne Imbernon
LZLéonore Zagdoun
Léonore Zagdoun
PBPierre Boulot
Pierre Boulot
EREric Renard
Eric Renard
AGAnne-Marie Guedj
Anne-Marie Guedj
Early gestational diabetes mellitus (eGDM) is diagnosed when fasting plasma glucose before 24 weeks of gestation (WG) is ≥ 5.1 mmol/L, whilst standard GDM is diagnosed between 24 and 28 WG by oral glucose tolerance test (OGTT). eGDM seems to have worse obstetric outcomes than standard GDM. We compared the rates of postpartum glucose metabolism disorders between women with early versus standard GDM in this prospective study on women with GDM from three university hospitals between 2014 and 2016. Patients were included if they were < 24 WG with at least one risk factor for GDM and excluded if they had type 2 diabetes. Patients were assigned to Group 1 (G1) for eGDM according to IADPSG: fasting blood glucose < 24 WG between 5.1 and 7 mmol/L. Group 2 (G2) consisted of patients presenting a standard GDM at 24–28 WG on OGTT results according to IADPSG: T0 ≥ 5.1 mmol/L or T60 ≥ 10.0 mmol g/L or T120 ≥ 8.5 mmol/L. The primary outcome was postpartum OGTT result. Five hundred patients were analysed, with 273 patients undergoing OGTT at 4–18 weeks postpartum: 192 patients in G1 (early) and 81 in G2 (standard). Patients in G1 experienced more insulin therapy during pregnancy than G2 (52.2% versus 32.5%, p < 0.001), but no patients were taking insulin postpartum in either group. G1 patients experienced less preterm labour (2.6% versus 9.1%, p = 0.043), more induced deliveries (38% versus 25%, p = 0.049) and reduced foetal complications (29.2% versus 42.0%, p = 0.048). There was no significant difference in the rate of postpartum glucose metabolism disorders (type 2 diabetes, impaired glucose tolerance, impaired fasting glycaemia) between groups: 48/192 (25%) in G1 and 17/81 (21%) in G2, p = 0.58. Thus the frequency of early postpartum glucose metabolism disorders is high, without difference between eGDM and standard GDM. This supports measurement of fasting plasma glucose before 24 WG and the threshold of 5.1 mmol/L seems appropriate until verification in future studies.Trial registration: NCT01839448, ClinicalTrials.gov on 22/04/2013.

1 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CBCyril Breuker
Cyril Breuker
AGAnne Marie Guedj
Anne Marie Guedj
MAMathilde Allan
Mathilde Allan
LCLoick Coinus
Loick Coinus
NMNicolas Molinari
Nicolas Molinari
ariane sultanariane sultan
ariane sultan
The objective of this study was to assess the impact of the COVID-19 pandemic on patients’ perceptions regarding infection risk and vaccination in subjects suffering from chronic diseases. A prospective observational multicentric study conducted from December 2020 to April 2021 in three French University Hospitals. Patients with chronic diseases were proposed to complete a questionnaire regarding the impact of the COVID-19 pandemic on infectious risk knowledge and vaccination. A total of 1151 patients were included and analyzed (62% of which were people with diabetes). The COVID-19 pandemic increased awareness of infectious risks by 19.3%, significantly more in people with diabetes (23.2%, from 54.4% to 67.0%, p < 0.01) when compared to the other high-risk patients (12.5%, from 50.5% to 56.8%, p = 0.06). Respectively, 30.6% and 16.5% of patients not up-to-date for pneumococcal and flu vaccines reported wanting to update their vaccination due to the COVID-19 pandemic. By contrast, the proportion of patients against vaccines increased during the COVID-19 pandemic (6.0% vs. 9.5%, p < 0.01). The COVID-19 pandemic has led to a small increase in awareness regarding the risks of infection in patients with chronic diseases, including people with diabetes, but without any change in willingness to be vaccinated. This underlines the urgent need to sensibilize people with diabetes to infection risk and the importance of vaccination.

1 December 2010 in Journal de Gynécologie Obstétrique et Biologie de la Reproduction
Verified
Journal Article
Closed access
AGA.-M. Guedj
A.-M. Guedj

24 August 2018 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
AGA.M. Guedj
A.M. Guedj
OGO. Gilly
O. Gilly
VTV. Taillard
V. Taillard
VCV. Cosma
V. Cosma
GLG. Lavigne
G. Lavigne
SDS. Droupy
S. Droupy

1 September 2017 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
EVE. Verbeke
E. Verbeke
OGO. Gilly
O. Gilly
SLS. Lumbroso
S. Lumbroso
DBdavid De Brauwere
david De Brauwere
BLB. Lallemant
B. Lallemant
AGA.M. Guedj
A.M. Guedj

1 September 2017 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
OGO. Gilly
O. Gilly
EVE. Verbeke
E. Verbeke
CNC. Neuwirth
C. Neuwirth
HSH. Sharara
H. Sharara
BLB. Lallemant
B. Lallemant
AGA.M. Guedj
A.M. Guedj